Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-26

Clinical Trial Update: Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oral ferrous sulfate to intravenous ferumoxytol in antepartum iron deficiency anemia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)
  • Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Stanford University | Conditions: Pregnancy Related, Anemia, Iron Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2025-08-26